Back to News
Market Impact: 0.1

Guardant Health, Inc. Grants 465,413 Target Performance-Based Restricted Stock Units to Each Co-CEO

Source: Nasdaq

Management & Governance

On November 2, 2026, Guardant Health’s independent directors approved performance-based restricted stock unit grants to co-CEOs and founders Helmy Eltoukhy and AmirAli Talasaz. The article text is truncated before providing grant amounts or performance terms.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News

From AllMind Research

Browse all research